AVISA PHARMA

Company Overview
Marketing Materials
Data Room
Management Bios
Videos
News & Articles
Contact Us
Company Overview
COMPANY OVERVIEW

 

The Avisa BreathTest is the world’s first point of care biomarker system that analyzes exhaled breath to detect & monitor pulmonary infection.

It is the world’s first breath test to detect & monitor pulmonary infections and is the only test that can differentiate a virulent bacterial infection from strep pneumonia and viral lung infection.

Deal Size
$2,000,000
Min Investment
$50,000
Industry
Other
Type of Investment
Convertible Debt
Location
Santa Fe, NM
Contact Us

Marketing Materials
MARKETING MATERIALS
Data Room
DATA ROOM
No items found
Management Bios
MANAGEMENT BIOS
David S. Joseph
President & CEO, Co-Founder
Graham S. Timmins, PH.D.
Chief Science Advisor
Elizabeth Perkett, MD
Consulting Chief Medical Officer
David Karshmer
Senior Vice President, Product Development
Matt Culler
Vice President, Finance
Videos
VIDEOS
No items found
News & Articles
NEWS & ARTICLES
Avisa BreathTest Video

A biomarker point-of-care test for rapidly detecting pulmonary infections. The Avisa BreathTest is a biomarker, quantitative, point-of-care test for rapidly detecting pulmonary infections due to certain virulent pathogens without the need to collect and culture sputum or other biological samples.

Please Visit Company Website For Latest News

Please visit the company’s news section of their website for their latest news https://www.avisapharma.com/news/

Contact Us
CONTACT US
OFFICE ADDRESS:
1660a Old Pecos Trail, Santa Fe, NM 87505, USA

P: 505-820-1400 x11 | 484-459-5076 cell
E: [email protected]